DIGA PHARMACEUTICAL GROUP SHARESLimited Company

ProjectTender Notice

Basic information of 1. project

1. Project (material) name: Sildenafil Citrate Control and Sildenafil Citrate Peak Identification Control

2. Place of demand: Degas Pharmaceutical Group Co., Ltd.Wendeng Gao refined

3. Demand overview: urgent need

4. Quality requirements: qualified

5. Time limit requirement: one week

6. Other Requirements: None

2. Supplier Qualification Requirements

1. A valid business license shall be provided for a legal person or other organization registered in the People's Republic of China.

2Must have the ability to bear civil liability independently.

3Must have a good business reputation and a sound financial accounting system, and be able to issue special VAT invoices.

4, must haveA good record of paying taxes and social security funds in accordance with the law within 3 years, and no major illegal records in business activities.

5, must have the necessary equipment and professional and technical capabilities to perform the project. Relevant supporting materials (including but not limited to professional qualifications, past successful cases and contracts) shall be provided.

6. Other conditions stipulated by laws and regulations.

3. Registration Instructions

1. The announcement of this invitation to tender ends at [2025] year 【02] month 【25], overdue will no longer be accepted.

2. If you are interested in participating, please sort out the above information (seal) before the deadline for announcement,Send as maildijiazbb@163.com；

Note: Please unify the mailtoName "Project Name Bidding Unit Name Preliminary Quotation". Please leave "Unit Contact Person, Position and Contact Information" (not less than two) in the body of the email.

3. Telephone number for consultation: 【0631-3857033】

4. After examination of qualified registration units, our staff will send detailed bidding documents by mail. Please check the mailbox in time. If you receive any, please reply and confirm by mail.

4. supervision and reporting methods

1. Report telephone number:0631-3855888

2. Report mailbox:zhengquanbu@dijiagroup.com

5. Other

The final interpretation of this tender belongs to our company. Please pay attention to the feedback information received by phone or email.